Tenax Therapeutics Announces Pricing Of About $9 Mln Offering Of Shares, Warrants; Stock Tanks 63%

Tenax Therapeutics, Inc. (TENX), a specialty pharmaceutical company, Thursday announced the pricing of the offering of 1.6 million shares and warrants to purchase up to 3.2 million shares at $5.65 per share, to raise around $9.04 million.

Following the announcement, Tenax's stock fell 63.88 percent, to $5.15 over the previous close of $14.26 on a volume of 1,441,883. It had traded between $5.12 and $108.8 in the last 52-week period on the Nasdaq.

The company said that proceeds from the offering would be used for the development and treatment of patients in its phase 3 trial of oral levosimendan and other general purposes.

The offering will close on or about February 12.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Editors Pick
ConocoPhillips (COP) reported Thursday that net earnings for the fourth quarter declined to $3.01 billion or $2.52 per share from $3.25 billion or $2.61 per share in the prior-year quarter. Excluding items, adjusted earnings for the quarter were $2.86 billion or $2.40 per share, compared to $3.38... Shares of A.P. Moller - Maersk A/S were losing around 16 percent in the morning trading on Denmark stock exchange after the logistics major reported Thursday a loss in its fourth quarter, compared to prior year's profit, on weak revenues. The results were impacted by downward pressure on rates and oversupply in Ocean, despite increasing volumes. Amid the ongoing Listeria monocytogenes outbreak, more and more products containing tainted cheese and other ingredients supplied by Rizo Lopez Foods Inc. are being recalled, according to the U.S. Food and Drug Administration. Fresh Creative Foods, a division of Reser's Fine Foods, Inc., has called back certain products, and Simply Fresh LLC. has recalled Rojo's Black Bean 6 Layer Dip.